Olema Pharmaceuticals, Inc. (OLMA ) Earnings
|
Expand Research on OLMA
| Next EPS Date | 8/11/26 | EPS Growth Rate | -7.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +5.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$0.55 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/12/26 | Q126 | -$0.52 | -$0.53 | +$0.01 | N/A | N/A | N/A |  | | Details | |
| 3/16/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A |
